Latest news with #EBRSystems
Herald Sun
6 days ago
- Business
- Herald Sun
Vital Signs Podcast: EBR's major milestones in WiSE CRT commercialisation
Don't miss out on the headlines from Stockhead. Followed categories will be added to My News. Vital Signs is a podcast series focused on investing, hosted by Senior Health and Biotech journalist Nadine McGrath. In this episode Nadine chats to John McCutcheon, the President and CEO of EBR Systems (ASX:EBR). EBR is focused on its lead technology, the WiSE CRT System, an innovative device designed to overcome the limitations of conventional Cardiac Resynchronisation Therapy (CRT) and is the only leadless left ventricular endocardial pacing (LVEP) device on the market. The company recently received FDA approval for the device in the US, opening the door to a mega market opportunity in one of the worlds largest healthcare markets. Earlier this month, the first two US commercial patients were treated with WiSE ahead of the company's reimbursement milestones, further demonstrating the clinical importance of the device. In this episode McCutcheon explains the significance of the technology, the reimbursement scheme and outlines the next steps for EBR as it prepares for commercial roll out. This podcast was developed in collaboration with EBR Systems, a Stockhead advertiser at the time of publishing. The interviews and discussions in this podcast are opinions only and not financial or investment advice. Listeners should obtain independent advice based on their own circumstances before making any financial decisions. Originally published as Vital Signs Podcast: EBR's major milestones in WiSE CRT commercialisation
Business Insider
10-06-2025
- Business
- Business Insider
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR) Receives a Buy from Bell Potter
In a report released today, Martyn Jacobs from Bell Potter maintained a Buy rating on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR – Research Report), with a price target of A$2.25. The company's shares closed last Friday at A$1.17. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Jacobs covers the Healthcare sector, focusing on stocks such as EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh, Trajan Group Holdings Ltd, and Medical Developments International Limited. According to TipRanks, Jacobs has an average return of -21.1% and a 13.58% success rate on recommended stocks. Currently, the analyst consensus on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh is a Strong Buy with an average price target of A$2.80, implying a 140.34% upside from current levels. In a report released on May 29, Wilsons also maintained a Buy rating on the stock with a A$3.00 price target.
News.com.au
06-06-2025
- Business
- News.com.au
Break it Down: EBR completes first US commercial implants of WiSE CRT system
Stockhead's Break it Down brings you today's leading market news in under 90 seconds. In this episode, host Tylah Tully looks at news from EBR Systems (ASX:EBR), who have implanted its first US commercial patients with the WiSE CRT System. The first US cases reflect two key uses for EBR's technology. Treating patients previously untreatable due to a non-functional C-S lead and patients with pacing-induced heart failure following a Micra leadless pacemaker implant. Watch the video to learn more. While EBR Systems is a Stockhead advertiser, it did not sponsor this content. Originally published as Break it Down: EBR completes first US commercial implants of WiSE CRT system
Business Insider
02-06-2025
- Business
- Business Insider
Bell Potter Reaffirms Their Buy Rating on Trajan Group Holdings Ltd (TRJ)
In a report released today, Martyn Jacobs from Bell Potter maintained a Buy rating on Trajan Group Holdings Ltd (TRJ – Research Report), with a price target of A$1.50. Confident Investing Starts Here: Jacobs covers the Healthcare sector, focusing on stocks such as EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh, Trajan Group Holdings Ltd, and Medical Developments International Limited. According to TipRanks, Jacobs has an average return of -21.3% and a 13.92% success rate on recommended stocks. Trajan Group Holdings Ltd has an analyst consensus of Moderate Buy, with a price target consensus of A$1.53. The company has a one-year high of A$1.31 and a one-year low of A$0.72. Currently, Trajan Group Holdings Ltd has an average volume of 29.48K.
Business Insider
30-05-2025
- Business
- Business Insider
Wilsons Sticks to Their Buy Rating for EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR)
Wilsons analyst Shane Storey maintained a Buy rating on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR – Research Report) yesterday and set a price target of A$3.00. The company's shares opened today at A$1.09. Confident Investing Starts Here: Storey covers the Healthcare sector, focusing on stocks such as Telix Pharmaceuticals, Monash IVF Group Ltd, and EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh. According to TipRanks, Storey has an average return of 7.5% and a 50.62% success rate on recommended stocks. EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh has an analyst consensus of Strong Buy, with a price target consensus of A$2.80, implying a 156.88% upside from current levels. In a report released on May 25, Bell Potter also maintained a Buy rating on the stock with a A$2.25 price target. The company has a one-year high of A$2.08 and a one-year low of A$0.82. Currently, EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh has an average volume of 1.08M.
